These observations point towards a critical involvement of micro-environmental factors such as hypoxia or nutrient-deprivation in steering cell fate after FOXO3-activation and questions FOXO3 as a “typical tumor suppressor protein” in NB therapy. The gene discussed is TCHP; the disease is neuroblastoma.